Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKahraman, Seda
dc.contributor.authorErul, Enes
dc.contributor.authorSeyyar, Mustafa
dc.contributor.authorGumusay, Ozge
dc.contributor.authorBayram, Ertugrul
dc.contributor.authorDemirel, Burcin Cakan
dc.contributor.authorAcar, Omer
dc.contributor.authorAksoy, Sercan
dc.contributor.authorBaytemur, Naziyet Kose
dc.contributor.authorSahin, Elif
dc.contributor.authorCabuk, Devrim
dc.contributor.authorBasaran, Gul
dc.contributor.authorPaydas, Semra
dc.contributor.authorYaren, Arzu
dc.contributor.authorGuven, Deniz Can
dc.contributor.authorErdogan, Atike Pinar
dc.contributor.authorDemirci, Umut
dc.contributor.authorYasar, Alper
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.contributor.authorHizal, Mutlu
dc.contributor.authorGulbagci, Burcu
dc.contributor.authorPaksoy, Nail
dc.contributor.authorDavarci, Sena Ece
dc.contributor.authorYilmaz, Funda
dc.contributor.authorDogan, Ozlem
dc.contributor.authorOrhan, Sibel Oyucu
dc.contributor.authorKayikcioglu, Erkan
dc.contributor.authorAytac, Ali
dc.contributor.authorKeskinkilic, Merve
dc.contributor.authorMocan, Eda Eylemer
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorAydin, Esra
dc.contributor.authorYucel, Hakan
dc.contributor.authorIsik, Deniz
dc.contributor.authorEren, Onder
dc.contributor.authorUluc, Basak Oyan
dc.contributor.authorOzcelik, Melike
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorAydiner, Adnan
dc.contributor.authorDemir, Hacer
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorCilbir, Ebru
dc.contributor.authorCubukcu, Erdem
dc.contributor.authorCetin, Bulent
dc.contributor.authorOktay, Esin
dc.contributor.authorErol, Cihan
dc.contributor.authorOkutur, Sadi Kerem
dc.contributor.authorYildirim, Nilgun
dc.contributor.authorAlkan, Ali
dc.contributor.authorSelcukbiricik, Fatih
dc.contributor.authorAksoy, Asude
dc.contributor.authorKarakas, Yusuf
dc.contributor.authorOzkanli, Gulhan
dc.contributor.authorDuman, Berna Bozkurt
dc.contributor.authorAydin, Dincer
dc.contributor.authorDulgar, Ozgecan
dc.contributor.authorEr, Muhammed Muhiddin
dc.contributor.authorTeker, Fatih
dc.contributor.authorYavuzsen, Tugba
dc.contributor.authorAykan, Musa Baris
dc.contributor.authorInal, Ali
dc.contributor.authorIriagac, Yakup
dc.contributor.authorKalkan, Nurhan Onal
dc.contributor.authorKeser, Murat
dc.contributor.authorSakalar, Teoman
dc.contributor.authorMenekse, Serkan
dc.contributor.authorKut, Engin
dc.contributor.authorBilgin, Burak
dc.contributor.authorKaraoglanoglu, Muge
dc.contributor.authorSunar, Veli
dc.contributor.authorOzdemir, Ozlem
dc.contributor.authorTurhal, Nazim Serdar
dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorYalcin, Bulent
dc.contributor.authorSendur, Mehmet Ali Nahit
dc.date.accessioned2025-10-16T15:15:28Z
dc.date.issued2023
dc.identifier.doi10.2217/fon-2022-1287
dc.identifier.otherWOS:000991646700001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6454
dc.publisherFUTURE MEDICINE LTD
dc.sourceFUTURE ONCOLOGY
dc.subjectCDK 4
dc.subject6 inhibitors
dc.subjectHER2\\-negative metastatic breast cancer
dc.subjectHR\\-positive
dc.subjectletrozole
dc.titleTreatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
dc.typeArticle; Early Access

Dosyalar

Koleksiyonlar

WOS